PAVmed, Inc. (PAVM)
2.79
+0.10
(+3.72%)
USD |
NASDAQ |
Oct 09, 16:00
2.79
0.00 (0.00%)
After-Hours: 20:00
PAVmed Cash from Operations (Quarterly) : -2.663M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.663M |
| March 31, 2026 | -2.62M |
| December 31, 2025 | -1.551M |
| September 30, 2025 | -0.896M |
| June 30, 2025 | -1.178M |
| March 31, 2025 | -1.581M |
| December 31, 2024 | 0.094M |
| September 30, 2024 | -8.883M |
| June 30, 2024 | -11.66M |
| March 31, 2024 | -13.11M |
| December 31, 2023 | -11.87M |
| September 30, 2023 | -11.09M |
| June 30, 2023 | -12.79M |
| March 31, 2023 | -16.29M |
| December 31, 2022 | -16.82M |
| September 30, 2022 | -19.34M |
| June 30, 2022 | -22.56M |
| March 31, 2022 | -12.26M |
| December 31, 2021 | -16.78M |
| September 30, 2021 | -8.018M |
| June 30, 2021 | -6.628M |
| March 31, 2021 | -9.168M |
| December 31, 2020 | -6.728M |
| Date | Value |
|---|---|
| September 30, 2020 | -5.839M |
| June 30, 2020 | -5.556M |
| March 31, 2020 | -3.791M |
| December 31, 2019 | -4.090M |
| September 30, 2019 | -2.878M |
| June 30, 2019 | -2.519M |
| March 31, 2019 | -3.870M |
| December 31, 2018 | -3.019M |
| September 30, 2018 | -1.866M |
| June 30, 2018 | -1.702M |
| March 31, 2018 | -2.200M |
| December 31, 2017 | -1.587M |
| September 30, 2017 | -2.372M |
| June 30, 2017 | -0.8236M |
| March 31, 2017 | -1.825M |
| December 31, 2016 | -1.203M |
| September 30, 2016 | -1.227M |
| June 30, 2016 | -1.506M |
| March 31, 2016 | -0.5187M |
| December 31, 2015 | -0.648M |
| September 30, 2015 | -0.3178M |
| June 30, 2015 | -0.2262M |
| March 31, 2015 | -0.0576M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Abbott Laboratories | 2.488B |
| AngioDynamics, Inc. | -15.33M |
| Alphatec Holdings, Inc. | 20.51M |
| AtriCure, Inc. | 22.19M |
| Baxter International, Inc. | 285.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.013M |
| Free Cash Flow | -7.782M |
| Free Cash Flow Per Share (Quarterly) | -0.4268 |
| Free Cash Flow to Equity (Quarterly) | -2.734M |
| Free Cash Flow to Firm (Quarterly) | -2.674M |
| Free Cash Flow Yield | -119.4% |